Literature DB >> 2412310

The effect of cyclosporin A on pulmonary fibrosis induced by butylated hydroxytoluene, bleomycin and beryllium sulfate.

L E Sendelbach, R C Lindenschmidt, H P Witschi.   

Abstract

Interstitial pulmonary fibrosis is characterized by an abnormal accumulation of fibroblasts with a resultant increase in lung collagen content. Previous research has implied a possible involvement of the T-lymphocyte in this process. We used cyclosporin A (Cy A), a known immunosuppressant, to deplete T-lymphocyte-dependent responses in animals following treatment with agents known to produce fibrosis; butylated hydroxytoluene (BHT), bleomycin and beryllium (Be). BHT-treated mice and bleomycin-treated rats showed significant reduction in total lung hydroxyproline content with Cy A (P less than 0.05). These results suggest a contribution of the T-lymphocyte in the overall process of fibrosis, but do not indicate its role as the sole causative agent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412310     DOI: 10.1016/0378-4274(85)90162-6

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  3 in total

Review 1.  New strategies for treatment of pulmonary fibrosis.

Authors:  S H Phan
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

2.  Efficacy of cyclosporin A for idiopathic pulmonary fibrosis.

Authors:  M Fukazawa; M Kawano; S Hisano; K Ueda; K Matsuba
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

Review 3.  Animal models of systemic sclerosis: their utility and limitations.

Authors:  Carol M Artlett
Journal:  Open Access Rheumatol       Date:  2014-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.